Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04179 (
MnSOD
)
2,777
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Oxidative injury has been implicated in the pathophysiology of neuronal injury and neurodegenerative disease. Antioxidant proteins provide an endogenous defense against such oxidative injury and may yield important clues to mechanisms of cytoprotection and neuronal recovery. Axotomy is the simplest model of neuronal injury and lesioning the sciatic nerve allows concurrent study of both motor (spinal cord) and sensory (dorsal root ganglia,
DRG
) neurons affected by the same injury. This study was designed to examine the expression of superoxide dismutase (SOD), an essential antioxidant protein, in motor and sensory neurons following complete axotomy of peripheral nerve. Immunocytochemical, quantitative immunoblot, and enzymatic activity assay techniques are used. By 12 days after axotomy, immunocytochemical expression of
Mn-SOD
is markedly increased in affected
DRG
and spinal cord. A similar increase in Cu/Zn-SOD is not seen in
DRG
or spinal cord. This immunocytochemical staining is associated with a significant increase in specific activity and
Mn-SOD
protein content as measured on quantitative immunoblots. This report suggests, for the first time, that
Mn-SOD
and not Cu/Zn-SOD increases in sensory neurons of the
DRG
and motor neurons of the spinal cord following distal axotomy of the sciatic nerve. Quantitative measurements of
Mn-SOD
following axotomy reveals that the increase in immunocytochemical reactivity is associated with an approximately 30% increase in specific activity when comparing lesioned and contralateral spinal cord samples. These data suggest that
Mn-SOD
may have a more significant role in the pathophysiology of neuronal injury than Cu/Zn-SOD.
...
PMID:Expression of superoxide dismutase following axotomy. 929 1